MBX Biosciences, Inc.’s MBX share price has dipped by 14.00%, which has investors questioning if this is right time to buy.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Incretin-mimetic drugs contribute to dramatic weight loss, but this does not solely mean fat loss. In this article, we ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

On the other hand, Hanmi Pharmaceutical's obesity treatment substance HM15275 is a triple-action agent that activates not only GLP-1 but also glucose-dependent insulinotropic polypeptide (GIP ...